These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 9314486)

  • 1. A life-threatening adverse reaction during trimethoprim-sulfamethoxazole desensitization in a previously hypersensitive patient infected with human immunodeficiency virus.
    Marsh BJ
    Clin Infect Dis; 1997 Sep; 25(3):754-6. PubMed ID: 9314486
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy and safety of desensitization to trimethoprim-sulfamethoxazole in human immunodeficiency virus-infected patients.
    Piketty C; Gilquin J; Kazatchkine MD
    J Infect Dis; 1995 Aug; 172(2):611. PubMed ID: 7622921
    [No Abstract]   [Full Text] [Related]  

  • 3. A life-threatening adverse reaction during trimethoprim-sulfamethoxazole desensitization in a previously hypersensitive patient infected with human immunodeficiency virus.
    Caumes E; Guermonprez G; Winter C; Katlama C; Bricaire F
    Clin Infect Dis; 1996 Dec; 23(6):1313-4. PubMed ID: 8953079
    [No Abstract]   [Full Text] [Related]  

  • 4. Trimethoprim/sulfamethoxazole desensitization.
    Cortese LM; Soucy DM; Endy TP
    Ann Pharmacother; 1996 Feb; 30(2):184-6. PubMed ID: 8835054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutathione in hypersensitivity to trimethoprim/sulfamethoxazole in patients with HIV infection.
    Rose EW; McCloskey WW
    Ann Pharmacother; 1998 Mar; 32(3):381-3. PubMed ID: 9533069
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy and safety of desensitization with sulfamethoxazole and trimethoprim in 48 previously hypersensitive patients infected with human immunodeficiency virus.
    Caumes E; Guermonprez G; Lecomte C; Katlama C; Bricaire F
    Arch Dermatol; 1997 Apr; 133(4):465-9. PubMed ID: 9126010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trimethoprim-sulfamethoxazole-induced sepsis-like syndrome in a patient with AIDS.
    O'Kane EB; Schneeweiss R
    J Am Board Fam Pract; 1996; 9(6):448-50. PubMed ID: 8923404
    [No Abstract]   [Full Text] [Related]  

  • 8. Rapid oral desensitization to trimethoprim-sulfamethoxazole in infants and children.
    Palusci VJ; Kaul A; Lawrence RM; Haines KA; Kwittken PL
    Pediatr Infect Dis J; 1996 May; 15(5):456-60. PubMed ID: 8724071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A severe hypersensitive reaction to trimethoprim-sulfamethoxazole in a patient infected with human immunodeficiency virus.
    Marinac JS; Stanford JF
    Clin Infect Dis; 1993 Jan; 16(1):178-9. PubMed ID: 8448304
    [No Abstract]   [Full Text] [Related]  

  • 10. Desensitization to co-trimoxazole (trimethoprim-sulphamethoxazole) in HIV-infected patients: is patch testing a useful predictor of reaction?
    Gompels MM; Simpson N; Snow M; Spickett G; Ong E
    J Infect; 1999 Mar; 38(2):111-5. PubMed ID: 10342651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Desensitization to cotrimoxazole, rifampicin and penicillin G in nine patients with prior hypersensitivity].
    Pujal Herranz M; Roca Massa M; Domínguez Tordera P; Codina Jané C; Ribas Sala J
    Farm Hosp; 2006; 30(4):254-9. PubMed ID: 17022720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trimethoprim-sulfamethoxazole (cotrimoxazole) desensitization in an HIV-infected 5-yr-old girl.
    Gómez-Traseira C; Boyano-Martínez T; Escosa-García L; Pedrosa M; Martín-Muñoz F; Quirce S
    Pediatr Allergy Immunol; 2015 May; 26(3):287-289. PubMed ID: 25692246
    [No Abstract]   [Full Text] [Related]  

  • 13. Restarting trimethoprim-sulfamethoxazole after a hypersensitivity reaction in patients infected with the human immunodeficiency virus.
    Everson-Mays RE; Weidle PJ
    Am J Health Syst Pharm; 1997 Jul; 54(13):1545-50. PubMed ID: 9217946
    [No Abstract]   [Full Text] [Related]  

  • 14. [Value of desensitization for reintroducing trimethoprim-sulfamethoxazole in hypersensitive patients with HIV infection].
    Caumes E
    Ann Med Interne (Paris); 1997; 148(2):172-6. PubMed ID: 9238444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse reactions to trimethoprim-sulfamethoxazole.
    Lee BL
    Clin Rev Allergy Immunol; 1996-1997 Winter; 14(4):451-5. PubMed ID: 9040971
    [No Abstract]   [Full Text] [Related]  

  • 16. A severe systemic reaction to trimethoprim-sulfamethoxazole in a patient infected with the human immunodeficiency virus.
    Martin GJ; Paparello SF; Decker CF
    Clin Infect Dis; 1993 Jan; 16(1):175-6. PubMed ID: 8448303
    [No Abstract]   [Full Text] [Related]  

  • 17. Successful outpatient graded administration of trimethoprim-sulfamethoxazole in patients without HIV and with a history of sulfonamide adverse drug reaction.
    Pyle RC; Butterfield JH; Volcheck GW; Podjasek JC; Rank MA; Li JT; Harish A; Poe KL; Park MA
    J Allergy Clin Immunol Pract; 2014; 2(1):52-8. PubMed ID: 24565769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse reactions to trimethoprim-sulfamethoxazole among children with human immunodeficiency virus infection.
    Rieder MJ; King SM; Read S
    Pediatr Infect Dis J; 1997 Nov; 16(11):1028-31. PubMed ID: 9384334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cotrimoxazole for prophylaxis or treatment of opportunistic infections of HIV/AIDS in patients with previous history of hypersensitivity to cotrimoxazole.
    Lin D; Li WK; Rieder MJ
    Cochrane Database Syst Rev; 2007 Apr; (2):CD005646. PubMed ID: 17443608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulfonamide Hypersensitivity: Fact and Fiction.
    Khan DA; Knowles SR; Shear NH
    J Allergy Clin Immunol Pract; 2019; 7(7):2116-2123. PubMed ID: 31495421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.